COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology

NCT04335773 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2022-02-16

No results posted yet for this study

Summary

Prospective cohort study of COVID-19 infection among children in Norway.

Conditions

  • Pediatric Respiratory Diseases
  • COVID
  • Fatigue Post Viral

Sponsors & Collaborators

  • St. Olavs Hospital

    collaborator OTHER
  • Helse Stavanger HF

    collaborator OTHER_GOV
  • Haukeland University Hospital

    collaborator OTHER
  • University Hospital of North Norway

    collaborator OTHER
  • Alesund Hospital

    collaborator OTHER
  • Norwegian Institute of Public Health

    collaborator OTHER_GOV
  • The University of New South Wales

    collaborator OTHER
  • University of Bristol

    collaborator OTHER
  • Sykehuset Ostfold

    collaborator OTHER
  • Nordlandssykehuset HF

    collaborator OTHER
  • Vestre Viken Hospital Trust

    collaborator OTHER
  • Helse Fonna

    collaborator OTHER
  • Helse Nord-Trøndelag HF

    collaborator OTHER
  • Oslo University Hospital

    collaborator OTHER
  • Sykehuset Innlandet HF

    collaborator OTHER
  • University Hospital, Akershus

    lead OTHER

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-03
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • Norway

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04335773 on ClinicalTrials.gov